Douglas G. Cheung
Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin
Cheung, Douglas G.; Buzzetti, Marta; Croce, Carlo M.; Leva, Gianpiero di
Citation
Cheung, D. G., Buzzetti, M., Croce, C. M., & Leva, G. D. (2018). Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin. Cancer Research, 78(13_Supplement), 1850-1850. https://doi.org/10.1158/1538-7445.am2018-1850
| Journal Article Type | Article |
|---|---|
| Publication Date | Jul 1, 2018 |
| Deposit Date | Jun 14, 2023 |
| Journal | Cancer Research |
| Print ISSN | 0008-5472 |
| Electronic ISSN | 1538-7445 |
| Publisher | American Association for Cancer Research |
| Peer Reviewed | Peer Reviewed |
| Volume | 78 |
| Issue | 13_Supplement |
| Pages | 1850-1850 |
| DOI | https://doi.org/10.1158/1538-7445.am2018-1850 |
| Keywords | Cancer Research; Oncology |
You might also like
Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin
(2018)
Journal Article
miRNAs in bone metastasis
(2017)
Journal Article
miRNA clusters as therapeutic targets for hormone-resistant breast cancer
(2015)
Journal Article
Erratum
(2014)
Journal Article
microRNAs as Anti-Cancer Therapy
(2014)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search